Efficacy and safety benefits of iGlarLixi versus insulin glargine 100 U/mL or lixisenatide in Asian Pacific people with suboptimally controlled type 2 diabetes on oral agents: the Lixi-Lan-O-AP randomized controlled trial
Multiple Sclerosis: Understanding the Condition Multiple sclerosis (MS) is a chronic, progressive neurological condition affecting the central nervous system, including the brain, spinal cord, and optic nerves
Since GLP-1 medications often cause loss of muscle mass along with body fat, its important to offset this as much as possible by eating protein
Results There were four RCTs involving 27,617 individuals (13,809 receiving semaglutide and 13,808 receiving placebo)
un anlisis de los datos de NHANES concluy que es extremadamente difcil alcanzar la IA nicamente a partir de fuentes alimentarias si no se consumen huevos (106)